LifeMD, Inc. (LFMD)
| Market Cap | 107.38M |
| Revenue (ttm) | 78.35M |
| Net Income (ttm) | -75.04M |
| Shares Out | 30.59M |
| EPS (ttm) | -3.11 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 238,390 |
| Open | 3.60 |
| Previous Close | 3.63 |
| Day's Range | 3.45 - 3.64 |
| 52-Week Range | 3.34 - 33.02 |
| Beta | 0.67 |
| Analysts | Strong Buy |
| Price Target | 15.50 (+341.6%) |
| Earnings Date | Nov 10, 2021 |
About LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medic...
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for LifeMD stock is "Strong Buy" and the 12-month stock price forecast is 15.50.
News
3 Medical Services Stocks to Buy Despite Near-Term Industry Woes
The Zacks Medical - Services industry is growing on digital healthcare adoption. AMN, AMEH and LFMD are set to gain the most.
LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform
Acquisition of Cleared Further Diversifies LifeMD's Telehealth Offerings to Encompass Allergy, Asthma, and Immunology
LifeMD to Participate in Upcoming January Investor Conferences
NEW YORK, Dec. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that management will participate in the following...
LifeMD to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022
CEO Schreiber to discuss changes made possible via proprietary virtual care platforms CEO Schreiber to discuss changes made possible via proprietary virtual care platforms
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Dec. 23, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD/LFMDP), a leading direct-to-patient telehealth company, today announced that its Board of Directors has authorized a cash dividend ...
LifeMD to Participate in the Stephens Annual Investment Conference
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) today announced that management will present at the Stephens Annual Investment Conference on Monday, November 2...
LifeMD, Inc. (LFMD) Reports Q3 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of 26.53% and 1.62%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
LifeMD to Release Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Hosted conference call to begin at 5:00 p.m. ET Hosted conference call to begin at 5:00 p.m. ET
LifeMD Announces Closing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulative Perpetual Preferred Stock
NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company today announced the closing of its previously announced un...
LifeMD Announces Closing of Public Offering of Common Stock and Exercise of the Underwriters' Option
NEW YORK, Oct. 04, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the closing of its previously announced underwrit...
LifeMD Announces Pricing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company today announced the pricing of its previously announced ...
LifeMD Announces Pricing of Public Offering of Common Stock
NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc . (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the pricing of its previously announced underwr...
LifeMD Announces Launch of Public Offering of Common Stock
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that it has commenced an underwritten registered...
LifeMD Announces Launch of Public Offering of 1,400,000 Shares of Preferred Stock
NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced it has commenced an underwritten registe...
LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment, prescripti...
LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for Patients
Strategic partnership provides LifeMD with a vertically integrated, best-in-class pharmacy fulfillment and e-prescribing technology platform and immediate access to nationwide pharmacy network Strategic...
New Strong Sell Stocks for August 26th
FSLY, GNSS, LFMD, NUAN, and QUOT have been added to the Zacks Rank #5 (Strong Sell) List on August 26, 2021
LifeMD, Inc. (LFMD) Reports Q2 Loss, Tops Revenue Estimates
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of -13.33% and 3.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
LifeMD Reports Q2 2021 Revenue Up 145% to Record $22.3 Million, Driven by Reduced Acquisition Costs and Strong Retention
NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the second quarter ended June 30, 2021. All figure compariso...
Earnings Preview: LifeMD, Inc. (LFMD) Q2 Earnings Expected to Decline
LifeMD, Inc. (LFMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LifeMD to Release Second Quarter 2021 Financial Results on Thursday, August 12, 2021
Hosted conference call to begin at 4:30 p.m. ET Hosted conference call to begin at 4:30 p.m. ET
LifeMD Teams with a Leading Provider of Diagnostic Services and Axle Health to Deliver Telehealth Access to At-Home D...
Patients Gain Access to Comprehensive Suite of Laboratory and Diagnostic Services at Preferred Pricing, Performed in the Comfort and Convenience of Home Patients Gain Access to Comprehensive Suite of La...
7 Meme Stocks to Buy for Their ‘To-the-Moon' Potential
These seven meme stocks to buy could be good picks for July as investor interest in these high-risk, high-return plays continues to grow. The post 7 Meme Stocks to Buy for Their ‘To-the-Moon' Potential ...
LifeMD Names Experienced Pharma Executive Alexander Mironov as President
A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare, totaling over $5 billion